Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

DOI Full Paper Access

507

Citations

27

References

2023

Year

Adrianus J. de Langen, Melissa L. Johnson, Julien Mazières, Anne‐Marie C. Dingemans, Giannis Mountzios, Miklos Pless, Jürgen Wolf, Martin Schüler, H. Léna, Ferdinandos Skoulidis,

Non-small-cell Lung CancerMedicinePathologyCancer TreatmentCancer GeneticsOncologyRadiation OncologySotorasib Versus DocetaxelLung CancerMolecular OncologyKrasg12c Mutation

References

	Year	Citations

Page 1

Page 1